Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Imunon, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- 0 vs. Q4 2025
- Shares held
- 503.6K
- +108.7K (+27.5%) vs. Q4 2025
- Total value
- $1.63M
- +$5.54K (+0.3%) vs. Q4 2025
- New holders
- 3
- 6 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 348,330 | $1.02M | 0.03% | +81,444+30.5% | Added |
| Riverview Capital Advisers, LLC | 34,364 | $247.8K | 0.08% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 48,056 | $141.3K | 0.00% | +48,056 | New |
| Geode Capital Management, LLC | 33,211 | $97.6K | 0.00% | +11,989+56.5% | Added |
| Vanguard Fiduciary Trust Co | 13,269 | $39.0K | 0.00% | +13,269 | New |
| HRT Financial LP | 12,055 | $35.0K | 0.00% | +12,055 | New |
| BlackRock, Inc. | 4,464 | $13.1K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,342 | $9.83K | 0.00% | −96−2.8% | Reduced |
| Morgan Stanley | 3,035 | $8.92K | 0.00% | +71+2.4% | Added |
| Tower Research Capital LLC (TRC) | 1,866 | $5.49K | 0.00% | +1,815+3,558.8% | Added |
| SBI Securities Co., Ltd. | 1,027 | $3.02K | 0.00% | +1+0.1% | Added |
| UBS Group AG | 575 | $1.69K | 0.00% | −1,022−64.0% | Reduced |
| Group One Trading, L.P. | 6 | $18 | 0.00% | −3−33.3% | Reduced |
| Federation des caisses Desjardins du Quebec | 5 | $15 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $5 | 0.00% | +1+100.0% | Added |
| FMR LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Steigerwald, Gordon & Koch Inc. | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| DRW Securities, LLC | 0 | $0 | 0.00% | −58,830−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |